tiprankstipranks
Trending News
More News >
Nissan Chemical Corporation (JP:4021)
:4021
Advertisement

Nissan Chemical (4021) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4021

Nissan Chemical

(Frankfurt:4021)

Select Model
Select Model
Select Model
Outperform 77 (OpenAI - 4o)
Rating:77Outperform
Price Target:
¥6,140.00
▲(18.35% Upside)
Nissan Chemical's strong financial performance, characterized by robust revenue growth and profitability, is the most significant factor driving the stock score. The technical analysis supports a stable upward trend, while the valuation is attractive with a reasonable P/E ratio and a solid dividend yield. The absence of earnings call data and corporate events does not impact the overall score.

Nissan Chemical (4021) vs. iShares MSCI Japan ETF (EWJ)

Nissan Chemical Business Overview & Revenue Model

Company DescriptionNissan Chemical Corporation engages in the chemicals, performance materials, agricultural chemicals, and pharmaceuticals businesses in Japan and internationally. Its chemical products include MELAMINE, an adhesive agent; high purity chemicals; AdBlue, an urea solution; ammonia, sulfuric, and nitric acid; TEPIC, an epoxy compound; Melamine Cyanurate, a salt of melamine and iso cyanuric acid; Nissan Reishi, a health food; phenylphosphonic acid; HI-LITE, a chlorinated isocyanulate; OPTBEADS, a melamine-formaldehyde resin and silica; and FINEOXOCOL, a saturated fatty alcohol and acid. The company also offers performance materials comprising display, semiconductor, and inorganic materials; agricultural chemicals, such as herbicides, insecticides, fungicides, etc. for use on agricultural land, as well as in golf courses and parks; and drug substances for antiparasite drugs for animals. In addition, it provides pharmaceutical products, such as LIVALO, a cholesterol reduction agent; LANDEL and FINTE, a dual type calcium antagonist that blocks calcium channels; and custom manufacturing and process researching services for pharmaceutical ingredients. Further, the company develops healthcare, information and communication materials, and environmental and energy materials. The company was formerly known as Nissan Chemical Industries, Ltd. and changed its name to Nissan Chemical Corporation in July 2018. Nissan Chemical Corporation was founded in 1887 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyNissan Chemical makes money through a multi-faceted revenue model driven by its diverse range of products and solutions. The company earns significant income from its chemical and performance materials divisions, which supply essential substances for various industrial applications, including electronics and automotive. The agricultural chemicals sector generates revenue through the sale of herbicides, insecticides, and fungicides that support global agricultural productivity. Additionally, the company benefits from its pharmaceuticals division by developing and licensing medical compounds and technologies. Strategic partnerships and collaborations with other corporations and research institutions also play a crucial role in enhancing its product offerings and expanding its market reach, thereby contributing to its overall earnings.

Nissan Chemical Financial Statement Overview

Summary
Nissan Chemical demonstrates strong financial performance with consistent revenue growth and robust profitability metrics. The balance sheet shows a solid financial position with low leverage and high equity, while cash flow management is healthy, though capital expenditure could be optimized.
Income Statement
85
Very Positive
Nissan Chemical demonstrates strong financial performance with consistent revenue growth, evident from a 10.9% increase in revenue from 2024 to 2025. The company maintains high profitability, with a gross profit margin of 46.3% and a net profit margin of 17.1% in 2025. EBIT and EBITDA margins also reflect efficiency and profitability. These metrics highlight the company's robust revenue-generating capacity and cost management.
Balance Sheet
80
Positive
The balance sheet of Nissan Chemical shows a solid financial position with a low debt-to-equity ratio of 0.17, indicating conservative leverage. The equity ratio stands at 70.5%, signifying strong equity financing. Return on equity is also favorable at 18.4%, demonstrating effective utilization of shareholders' funds. These factors collectively suggest financial stability and a low-risk profile.
Cash Flow
75
Positive
Nissan Chemical exhibits healthy cash flow management, with a substantial free cash flow growth rate of 238.4% from 2024 to 2025. The operating cash flow to net income ratio of 1.38 indicates efficient cash conversion. However, the free cash flow to net income ratio is slightly lower at 1.00, indicating room for improvement in capital expenditures or operational efficiency.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue262.55B251.37B226.71B228.06B207.97B209.12B
Gross Profit121.69B116.54B104.78B106.80B101.09B87.75B
EBITDA76.13B74.55B66.11B67.84B64.45B55.97B
Net Income45.34B43.04B38.03B41.09B38.78B33.47B
Balance Sheet
Total Assets334.50B330.76B323.46B298.71B279.69B265.51B
Cash, Cash Equivalents and Short-Term Investments33.55B27.45B22.74B29.65B34.66B32.38B
Total Debt49.82B40.47B40.98B27.29B22.71B22.67B
Total Liabilities98.95B94.58B92.56B77.19B71.68B64.95B
Stockholders Equity232.20B233.29B227.47B218.42B205.91B198.83B
Cash Flow
Free Cash Flow42.68B43.01B12.70B15.05B29.10B30.40B
Operating Cash Flow60.17B59.18B33.70B35.23B41.95B39.94B
Investing Cash Flow-18.16B-17.61B-18.74B-19.64B-12.39B-12.85B
Financing Cash Flow-41.65B-35.65B-22.10B-25.03B-27.87B-25.63B

Nissan Chemical Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price5188.00
Price Trends
50DMA
5289.75
Negative
100DMA
4833.30
Positive
200DMA
4580.59
Positive
Market Momentum
MACD
-0.23
Positive
RSI
43.75
Neutral
STOCH
19.57
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4021, the sentiment is Neutral. The current price of 5188 is below the 20-day moving average (MA) of 5347.28, below the 50-day MA of 5289.75, and above the 200-day MA of 4580.59, indicating a neutral trend. The MACD of -0.23 indicates Positive momentum. The RSI at 43.75 is Neutral, neither overbought nor oversold. The STOCH value of 19.57 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4021.

Nissan Chemical Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
€706.54B15.6420.91%3.32%13.93%23.19%
71
Outperform
$1.05T28.595.90%1.12%1.60%-6.74%
68
Neutral
$706.90B14.656.04%4.50%3.71%-19.97%
65
Neutral
$745.37B76.930.92%2.64%0.98%
62
Neutral
$537.30B35.282.06%3.25%0.55%-69.21%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
57
Neutral
$1.13T46.061.29%3.92%-6.66%-78.39%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4021
Nissan Chemical
5,188.00
57.49
1.12%
JP:3405
Kuraray Co
1,659.00
-324.32
-16.35%
JP:4188
Mitsubishi Chemical Holdings
816.60
19.49
2.45%
JP:4004
Showa Denko KK
5,794.00
2,152.67
59.12%
JP:4005
Sumitomo Chemical Co
455.20
56.78
14.25%
JP:4042
Tosoh
2,221.50
406.70
22.41%

Nissan Chemical Corporate Events

Nissan Chemical Advances Share Buyback Program
Aug 4, 2025

Nissan Chemical Corporation has repurchased 440,000 of its own common shares on the Tokyo Stock Exchange, amounting to a total cost of 2,022,443,700 yen, as part of its ongoing share buyback program. This move is part of a broader strategy approved by the Board of Directors to repurchase up to 2,500,000 shares by March 31, 2026, reflecting the company’s efforts to enhance shareholder value.

The most recent analyst rating on (JP:4021) stock is a Buy with a Yen5600.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.

Nissan Chemical Announces Share Repurchase Program
Jul 2, 2025

Nissan Chemical Corporation has announced the repurchase of 320,000 of its own shares on the Tokyo Stock Exchange, amounting to a total purchase cost of 1,351,956,000 yen. This move is part of a broader strategy approved by the Board of Directors to repurchase up to 2,500,000 shares, reflecting a commitment to enhancing shareholder value and optimizing capital structure.

The most recent analyst rating on (JP:4021) stock is a Buy with a Yen5800.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.

Nissan Chemical Announces Share Repurchase Plan
May 15, 2025

Nissan Chemical Corporation has announced a decision by its Board of Directors to repurchase up to 2,500,000 of its own common shares, representing 1.84% of the total shares outstanding, excluding treasury shares. This move, with a total repurchase amount of up to 9 billion yen, aims to facilitate a flexible capital policy in response to the evolving business environment, potentially impacting the company’s market positioning and shareholder value.

The most recent analyst rating on (JP:4021) stock is a Buy with a Yen5600.00 price target. To see the full list of analyst forecasts on Nissan Chemical stock, see the JP:4021 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 07, 2025